Cargando…
The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas
The presence of systemic inflammation has been reported to be associated with poor prognosis in patients with soft tissue sarcoma (STS). The cytokine interleukin-6 (IL-6) has pleiotropic effects on various cell types in the tumor microenvironment. The aim of the present study was to determine whethe...
Autores principales: | Hagi, Tomohito, Nakamura, Tomoki, Iino, Takahiro, Matsubara, Takao, Asanuma, Kunihiro, Matsumine, Akihiko, Sudo, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575335/ https://www.ncbi.nlm.nih.gov/pubmed/28851899 http://dx.doi.org/10.1038/s41598-017-08781-6 |
Ejemplares similares
-
Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
por: Nakamura, Koichi, et al.
Publicado: (2020) -
Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2017) -
Prognostic Significance of Thrombomodulin mRNA in High‐Grade Soft Tissue Sarcomas after 10 years
por: Asanuma, Kunihiro, et al.
Publicado: (2020) -
Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score
por: Nakamura, Tomoki, et al.
Publicado: (2022) -
Combination of Everolimus and Bortezomib Inhibits the Growth and Metastasis of Bone and Soft Tissue Sarcomas via JNK/p38/ERK MAPK and AKT Pathways
por: Nakamura, Koichi, et al.
Publicado: (2023)